OR of CX3CR1 on CD14 + CD16- monocyte on HCC risk was estimated to be 0.784(95% CI 0.679–0.906, P = 0.981 × 10–3) by using IVW approach. This evidence concerns the gene CX3CR1 and hepatocellular carcinoma.